What should you expect from your pathway analysis tools? When it comes to data-driven science, your results are only as…

Here’s the scenario – You’re a passionate scientist in a leading pharmaceutical company hoping to uncover a transformative drug candidate….

How to easily create, manage and share adverse outcome pathways to accelerate drug discovery programs Scientists working in drug discovery…

Do you ever struggle to formulate hypotheses based on your experimental expression data? You may be comparing results from healthy…

Ever wonder what goes on behind the scenes in R&D at QIAGEN Digital Insights? Our team of expert scientists is…

Basic pathway analysis has several limitations that can slow down research progress and hinder insights from biological data. One of…

‘Omics research has made it easy to gather large volumes of data on differentially expressed genes in various conditions. Changes…

Researchers across the world are using QIAGEN Digital Insights solutions to accelerate their work in a variety of applications Powerful…

  Neurofibromatosis (NF) is a genetic disorder that causes tumors to form on nerve tissue. These tumors can develop anywhere…

QIAGEN collaborates with a team from the University of Munich by applying bioinformatics software tools OmicSoft ArrayStudio and Ingenuity Pathway Analysis (IPA) to discover progranulin as a novel and sensitive biomarker for sepsis.

Researchers across the world are using Ingenuity Pathway Analysis to accelerate their work in a variety of applications, including the…

Introduction to the QIAseq miRNA library kit support in the Biomedical Genomics Analysis plugin for CLC Genomics Workbench The QIAseq…